[The association between NAT2 polymorphism and anti-tuberculosis drug-induced hepatitis].
Wu
Yu-Mei
YM
Department of Medcine, Shenzhen Third Peoples Hospital, Guangdong Medical College, Shenzhen 518020, China.
Luo
Zi-Yi
ZY
Zhang
Hong-Mei
HM
Peng
Jin-Fu
JF
Liu
Sai-Yun
SY
Wang
Min
M
D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects*; D001191:Arylamine N-Acetyltransferase / Q000235:genetics*; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D055815:Young Adult
D000995:Antitubercular Agents; D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human; D007538:Isoniazid